Sullivan N, Lyne L
Imperial Cancer Research Fund, Clare Hall Laboratories, Potters Bar, Herts., Great Britain.
Mutat Res. 1990 Nov;245(3):171-5. doi: 10.1016/0165-7992(90)90046-m.
We report the hypersensitivity of SV40-transformed fibroblasts derived from ataxia telangiectasia (AT) patients to calicheamicin gamma 1I. In common with other free-radical generating agents such as bleomycin and ionizing radiation, treatment with calicheamicin gamma 1I reveals AT derived lines to be 6-fold more sensitive to this drug when compared to controls. Furthermore, in common with ionizing radiation, AT cells did not show dose-dependent inhibition of DNA synthesis after treatment with calicheamicin gamma 1I.